StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) stock

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Oncotelic Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Oncotelic Therapeutics's pe ratio was 0.0× on Oct 19, 2026, against 5.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.0×−0.6
2023Jul 31, 20230.7×−1.0
2022Dec 30, 20221.7×–

More Oncotelic Therapeutics figures

See a number that looks wrong?